IRB-Brasil Resseguros (IRBR3) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
28 Oct, 2026Executive summary
2023 closed with BRL 114 million net income, below the BRL 120 million expectation, and BRL 155 million in underwriting results for the last 12 months.
Portfolio cleanup improved underwriting: the annual loss ratio fell to 70% from 104% in 2022, while the combined ratio improved to 109% from 137%.
Strategy centers on Brazil and Latin America, with growth tied to pricing discipline, profitability and better capital use.
Financial highlights
FY2023 acquisition costs were BRL 1.047 billion, down 5% YoY; Q4 costs rose to BRL 374 million from BRL 249 million due mainly to advances on life commissions.
FY2023 administrative expenses rose 7.4% reported; excluding BRL 25 million tied to the DOJ agreement and BRL 13 million in voluntary termination costs, expenses were BRL 317 million, down 3.9% from BRL 330 million.
Financial and equity result was BRL 125 million in Q4 and BRL 549 million for FY2023; excluding favorable court-decision effects, FY result exceeded 2022 despite lower assets under management.
Operating cash flow improved YoY in recent quarters; overdue operational credits fell 11% QoQ, net overdue credits 47%, and third-party deposits 33%.
Outlook and guidance
2024 premium growth target is ~10%, with a combined ratio in the region of 95%; management said growth may be lower rather than cut prices.
FY2024 growth is intended to align with the market and be accompanied by a substantial increase in profit, with capital allocated by business line and returns assessed deal by deal.
January 2024 IFRS 4 results: net income BRL 36.8 million, underwriting result BRL 45 million, and combined ratio 97%; non-life combined ratio was 95.3%.
Management expects to finish accumulating losses by end-2024 and may then resume dividends; receipt of precatory bonds was expected in April 2024.
Latest events from IRB-Brasil Resseguros
- Drought drove a BRL 273 million Q2 loss as recovery and capital actions advanced.IRBR3
Q2 2022 - IFRS 4 profitability improved, while catastrophe exposure remains uncertain.IRBR3
Q1 2024 - Net income up 35% to R$504.8M (SUSEP), with strong capital, dividends, and ESG progress.IRBR3
Q4 2025 - 3Q25 net income ranged from R$99M to R$474M, with 251% solvency and strong P&C growth.IRBR3
Q3 2025 - Net profit and underwriting soared, with improved ratios and robust solvency at 237%.IRBR3
Q2 2025 - Net income more than doubled, with improved underwriting and strong capital ratios.IRBR3
Q3 2024 - 2Q24 net income jumped to R$65 million, with improved ratios and strong capital despite flood claims.IRBR3
Q2 2024 - Turnaround year with R$805.7M net income, strong non-life results, and robust capital ratios.IRBR3
Q4 2024 - Net income for Q1 2025 ranged from R$118.6M to R$135M, with strong solvency and lower premiums.IRBR3
Q1 2025